Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction - PubMed (original) (raw)

Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction

Iwona Swiatkiewicz et al. Inflamm Res. 2012 Jul.

Abstract

Objective: To assess the usefulness of in-hospital measurement of C-reactive protein (CRP) concentration in comparison to well-established risk factors as a marker of post-infarct left ventricular systolic dysfunction (LVSD) at discharge.

Materials and methods: Two hundred and four consecutive patients with ST-segment-elevation myocardial infarction (STEMI) were prospectively enrolled into the study. CRP plasma concentrations were measured before reperfusion, 24 h after admission and at discharge with an ultra-sensitive latex immunoassay.

Results: CRP concentration increased significantly during the first 24 h of hospitalization (2.4 ± 1.9 vs. 15.7 ± 17.0 mg/L; p < 0.001) and persisted elevated at discharge (14.7 ± 14.7 mg/L), mainly in 57 patients with LVSD (2.4 ± 1.8 vs. 25.0 ± 23.4 mg/L; p < 0.001; CRP at discharge 21.9 ± 18.6 mg/L). The prevalence of LVSD was significantly increased across increasing tertiles of CRP concentration both at 24 h after admission (13.2 vs. 19.1 vs. 51.5 %; p < 0.0001) and at discharge (14.7 vs. 23.5 vs. 45.6 %; p < 0.0001). Multivariate analysis demonstrated CRP concentration at discharge to be an independent marker of early LVSD (odds ratio of 1.38 for a 10 mg/L increase, 95 % confidence interval 1.01-1.87; p < 0.04).

Conclusion: Measurement of CRP plasma concentration at discharge may be useful as a marker of early LVSD in patients after a first STEMI.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

C-reactive protein plasma concentrations as mean values and standard deviations on admission, 24 h after admission and at hospital discharge in patients with and without early post-infarct left ventricular systolic dysfunction. LVEF left ventricular ejection fraction

Fig. 2

Fig. 2

Incidence of global left ventricular systolic dysfunction at hospital discharge according to tertiles of C-reactive protein plasma concentration 24 h after admission. CRP C-reactive protein, LVEF left ventricular ejection fraction

Fig. 3

Fig. 3

Incidence of global left ventricular systolic dysfunction at hospital discharge according to tertiles of C-reactive protein plasma concentration at discharge. CRP C-reactive protein, LVEF left ventricular ejection fraction

References

    1. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol. 2006;97(10A):13F–25F. doi: 10.1016/j.amjcard.2006.03.005. - DOI - PubMed
    1. Velazquez EJ, Francis GS, Armstrong PW, Aylward PE, Diaz R, O’Connor CM, et al. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALLIANT Registry. Eur Heart J. 2004;25:1911–1919. doi: 10.1016/j.ehj.2004.08.006. - DOI - PubMed
    1. Cleland JG, Torabi A, Khan NK. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005;91(Suppl 2):ii7–ii13. doi: 10.1136/hrt.2005.062026. - DOI - PMC - PubMed
    1. Kümler T, Gislason GH, Køber L, Torp-Pedersen C. Persistence of the prognostic importance of left ventricular systolic function and heart failure after myocardial infarction: 17-year follow-up of the TRACE register. Eur J Heart Fail. 2010;12:805–811. doi: 10.1093/eurjhf/hfq071. - DOI - PubMed
    1. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31–47. doi: 10.1016/S0008-6363(01)00434-5. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources